Research has shown that glucose levels, the brain’s primary source of fuel, in the central nervous system diminishes in aging, and some researchers suggest that…
In Being Patient’s LiveTalk series, Dr. David Weidman, associate medical director for research at the Banner Alzheimer’s Institute, shares insights on Eli Lilly’s investigational Alzheimer’s…
In the 1990s, the idea that clumps of beta-amyloid proteins are the main culprits of Alzheimer’s took off, and this line of thought —…
Following a diagnosis of mild cognitive impairment, patients can find themselves in a state of limbo, caught between being cognitively normal and living with…
Shreya Mcleod, a titled sports and musculoskeletal physiotherapist, and James F. Donnelly, a lecturer and researcher in Psychology at Southern Cross University, share insights…
Image: Aduhelm, Biogen/AP. “The approach I’ve been taking is that each decision about whether or not to offer this as a treatment has to…
When Kathy Kenyon’s parents — both with early-stage dementia — moved to the Washington, D.C. area, it took months for medical records to be…
Instead of developing a new drug from the ground up — a time-consuming and costly process — experts say that repurposing medications could accelerate…
For retired neurologist Daniel Gibbs, an Alzheimer’s diagnosis gave him not only a sense of relief, but a new lifestyle: one of healthier living,…
Retired neurologist Daniel Gibbs speaks about his own Alzheimer’s diagnosis, his unusual and severe case of side effects in aducanumab (Aduhelm) clinical trials, and…
In light of last week’s long-awaited FDA decision on experimental Alzheimer’s treatment aducanumab, a panel of clinical trials experts looks at why Alzheimer’s drug…
Looking for answers about Alzheimer’s treatment Aduhelm (generic name aducanumab)? Here’s a primer on what it is, what it does, and more, according to…
Cinical trial investigators for aducanumab (Aduhelm) discuss the significance of the drug’s recent FDA approval, the controversy surrounding its efficacy, and the uncertainty ahead….
A dementia diagnosis represents a new chapter in life: As people contend with the challenges that accompany the illness, they could also find new…
Geri Taylor, a participant in the aducanumab (Aduhelm) clinical trial, and her husband Jim share insights about taking part in the research. UPDATE: 3…